Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver sulfadiazine vs povidone iodine for healing in 30–50% burn patients
IRCT20240126060819N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silver sulfadiazine and povidone-iodine in burn injury (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jan 2024; status: completed.
02
Drugs
silver sulfadiazinepovidone-iodine
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20240126060819N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240126060819N1.